tiprankstipranks
Trending News
More News >
Intuitive Surgical (DE:IUI1)
XETRA:IUI1
Germany Market
Advertisement

Intuitive Surgical (IUI1) Earnings Dates, Call Summary & Reports

Compare
30 Followers

Earnings Data

Report Date
Jan 22, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.92
Last Year’s EPS
1.9
Same Quarter Last Year
Moderate Buy
Based on 19 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 21, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflected strong growth in revenue, procedures, and technological advancements with successful international expansion and positive clinical outcomes. However, challenges persist in the Chinese market and domestic bariatric procedures decline, with some concerns over net placements.
Company Guidance
In the third quarter of 2025, Intuitive Surgical, Inc. reported a strong financial performance marked by a 23% increase in revenue, reaching $2.5 billion, and a 30% growth in earnings. The company saw a 20% rise in total worldwide procedure growth, driven by a 19% increase in da Vinci procedures and a 52% surge in ION procedures. Utilization of da Vinci systems grew by 4%, while the installed base increased by 13% to almost 10,800 systems. The company placed 427 da Vinci systems, including 240 da Vinci V systems, contributing to the significant growth. Internationally, procedure growth was robust, with the da Vinci system seeing a 24% increase and a quadrupling of ION procedures. Intuitive Surgical's focus on delivering advanced features and digital tools, such as the da Vinci V's force feedback, has enhanced system capabilities and surgeon autonomy, supporting the company's vision of improving surgical outcomes and expanding access to minimally invasive care.
Strong Worldwide Procedure Growth
Total worldwide procedure growth was 20% with da Vinci and ION procedures increasing by 19% and 52% respectively.
Significant Revenue and Earnings Growth
Revenue grew 23% to $2.5 billion and earnings increased 30% year-over-year, reflecting strong operating discipline.
Successful Launch of da Vinci V
240 da Vinci V systems were placed, with the installed base now reaching 929 systems, driving higher utilization and efficiency.
Expansion into New Markets
First systems placed in Japan and Europe, with positive early feedback from these international markets.
Innovative Technological Advancements
FDA 510(k) clearance for software updates, enhancing surgeon awareness and intraoperative decision-making.
Positive Clinical Outcomes
Studies showed significant improvements in diagnostic yield and early-stage cancer diagnosis using ION and integrated mobile cone beam CT.

Intuitive Surgical (DE:IUI1) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DE:IUI1 Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jan 22, 2026
2025 (Q4)
1.92 / -
1.904
Oct 21, 2025
2025 (Q3)
1.72 / 2.07
1.58530.43% (+0.48)
Jul 22, 2025
2025 (Q2)
1.66 / 1.89
1.53323.03% (+0.35)
Apr 22, 2025
2025 (Q1)
1.50 / 1.56
1.29220.67% (+0.27)
Jan 23, 2025
2024 (Q4)
1.54 / 1.90
1.37838.13% (+0.53)
Oct 17, 2024
2024 (Q3)
1.41 / 1.58
1.25826.03% (+0.33)
Jul 18, 2024
2024 (Q2)
1.33 / 1.53
1.22325.35% (+0.31)
Apr 18, 2024
2024 (Q1)
1.22 / 1.29
1.05921.95% (+0.23)
Jan 23, 2024
2023 (Q4)
1.28 / 1.38
1.05930.08% (+0.32)
Oct 19, 2023
2023 (Q3)
1.22 / 1.26
1.02522.69% (+0.23)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DE:IUI1 Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 21, 2025
€400.95
Jul 22, 2025
€437.45€444.60+1.63%
Apr 22, 2025
€416.05€439.25+5.58%
Jan 23, 2025
€583.40€552.90-5.23%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Intuitive Surgical (DE:IUI1) report earnings?
Intuitive Surgical (DE:IUI1) is schdueled to report earning on Jan 22, 2026, After Close (Confirmed).
    What is Intuitive Surgical (DE:IUI1) earnings time?
    Intuitive Surgical (DE:IUI1) earnings time is at Jan 22, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Intuitive Surgical stock?
          The P/E ratio of Intuitive Surgical is N/A.
            What is DE:IUI1 EPS forecast?
            DE:IUI1 EPS forecast for the fiscal quarter 2025 (Q4) is 1.92.

              Intuitive Surgical (DE:IUI1) Earnings News

              Intuitive Surgical (ISRG) Q3 Earnings Preview: Here’s What to Expect
              Premium
              Market News
              Intuitive Surgical (ISRG) Q3 Earnings Preview: Here’s What to Expect
              1y ago
              ISRG Earnings: Intuitive Surgical Gains after Q2 Earnings Beat
              Premium
              Market News
              ISRG Earnings: Intuitive Surgical Gains after Q2 Earnings Beat
              1y ago
              Intuitive (NASDAQ:ISRG) Gains after Better-than-Expected Q4 Results
              Premium
              Market News
              Intuitive (NASDAQ:ISRG) Gains after Better-than-Expected Q4 Results
              2y ago
              Intuitive Surgical (NASDAQ:ISRG) Plunges on Q3 Revenue Miss
              Premium
              Market News
              Intuitive Surgical (NASDAQ:ISRG) Plunges on Q3 Revenue Miss
              2y ago
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis